Cue Biopharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cue Biopharma and other ETFs, options, and stocks.

About CUE

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology).

CEO

Usman Azam

CEOUsman Azam

Employees

Employees41

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2014

Founded2014

Employees

Employees41

CUE Key Statistics

Market cap

56.70M

Market cap56.70M

Price-Earnings ratio

-1.34

Price-Earnings ratio-1.34

Dividend yield

—

Dividend yield—

Average volume

177.43K

Average volume177.43K

High today

$0.7655

High today$0.7655

Low today

$0.725

Low today$0.725

Open price

$0.7652

Open price$0.7652

Volume

202.32K

Volume202.32K

52 Week high

$1.99

52 Week high$1.99

52 Week low

$0.5406

52 Week low$0.5406

People also own

Based on the portfolios of people who own CUE. This list is generated using Robinhood data, and it’s not a recommendation.